CEA is a recommended prognostic marker for monitoring tumor progression in colon cancer [16–19], and examining 12 nodes might be insufficient for CEA-elevated colon cancer patients who were characterized by higher risk of lymph node metastasis and poor prognosis. The gene discussed is CEACAM5; the disease is malignant colon neoplasm.